A Phase II study of Axitinib as maintenance for patients with advanced colorectal carcinoma.

Trial Profile

A Phase II study of Axitinib as maintenance for patients with advanced colorectal carcinoma.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 11 Oct 2016

At a glance

  • Drugs Axitinib (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Acronyms TTD-11-01
  • Most Recent Events

    • 11 Oct 2016 Results assessing efficacy and safety presented at the 41st European Society for Medical Oncology Congress.
    • 20 Apr 2016 Status changed from active, no longer recruiting to discontinued due to absence of patients recruitment.
    • 18 Nov 2014 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top